The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of October 2020. This month there are three guidelines, one technology appraisal and one antimicrobial guideline that impact upon primary care.
The COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community guideline has been updated. It aims to provide recommendations for managing COVID‑19 symptoms for patients in the community, including at the end of life. It also includes recommendations about managing medicines for these patients, and protecting staff from infection. The updated has amended recommendations on taking into account a patient’s existing medicines with reference to the MHRA advice on warfarin and other anticoagulants.
The Rheumatoid arthritis in adults: management guideline has been updated. It covers diagnosing and managing rheumatoid arthritis. It aims to improve quality of life by ensuring that people with rheumatoid arthritis have the right treatment to slow the progression of their condition and control their symptoms. This update amended the 'treat to target' recommendations to clarify that multiple disease-modifying anti-rheumatic drugs can be offered one after the other to achieve treatment targets.
The Behaviour change: digital and mobile health interventions guideline has been published. It covers interventions that use a digital or mobile platform to help people eat more healthily, become more active, stop smoking, reduce their alcohol intake or practise safer sex. The interventions include those delivered by text message, apps, wearable devices or the internet. The guideline only includes those that are delivered by the technology itself and not by healthcare professionals using technology to deliver interventions.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.